Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03187535 · ClinicalTrials.gov registry record · NA
Effect of TEAS on PONV After Spinal Surgery
A NA study of PONV, sponsored by Jyoti Pandya.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT03187535 is a NA study of PONV that is actively recruiting participants, run by Jyoti Pandya. The registered enrollment target is 72 participants, below the 525-participant average among 3 other PONV trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03187535, a NA study of PONV, is actively recruiting participants, sponsored by Jyoti Pandya.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research will utilize electroacupuncture, a type of needleless acupuncture that uses electrostimulation, in a randomized, double blind study, to evaluate the incidence of post-operative nausea and vomiting (PONV) in patients undergoing spinal surgeries with the transcutaneous electrical acupoint stimulation (TEAS) compared to patients without TEAS.
Conditions Studied
Interventions
- DEVICE TEAS via ES-130
- OTHER No TEAS
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2026-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03187535
The ClinicalTrials.gov registry entry for NCT03187535 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 525-participant average among 3 other PONV trials with a reported enrollment target (86% lower). The listed sponsor is Jyoti Pandya, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PONV appearing as the primary indexed condition, and to 2 interventions - of which TEAS via ES-130 is the first listed.
NCT03187535 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03187535 about?
NCT03187535 is a clinical study titled "Effect of TEAS on PONV After Spinal Surgery". The proposed research will utilize electroacupuncture, a type of needleless acupuncture that uses electrostimulation, in a randomized, double blind study, to evaluate the incidence of post-operative nausea and vomiting (PONV) in patients undergoing spinal surgeries with the transcutaneous electrical...
What is the current status of trial NCT03187535?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2018-08-01. Estimated completion is 2026-12-20.
What conditions does trial NCT03187535 study?
This clinical trial studies the following conditions: PONV.
What interventions are being tested in trial NCT03187535?
The interventions under investigation include: TEAS via ES-130 (DEVICE), No TEAS (OTHER).
Who is sponsoring clinical trial NCT03187535?
This trial is sponsored by Jyoti Pandya, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03187535 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PONV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.